AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2018

May 17, 2018

32418_dirs_2018-05-17_722d528d-d63b-4d4a-8c8c-d52e8ed9f5b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2018-05-15

Reporting Person: Jaksch Frank L Jr (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	201557	Direct
Common Stock	2075052	Indirect

Footnotes

F1: This Form 4 is being filed to amend the Form 4 filed on May 16, 2018. The purchases of common stock reported on such Form 4 did not in fact occur for the Reporting Person's account. The Reporting Person currently owns only the number of shares of common stock reflected in Column 5 of Table I.